• Skip to primary navigation
  • Skip to main content
NC Harm Reduction Coalition

NC Harm Reduction Coalition

Treating every person with dignity and respect

  • About
    • What is Harm Reduction?
    • Staff
      • Board of Directors
    • Contact
      • Media Linkage
        • Media Mentions
          • 2016
          • 2015
          • 2014
          • 2013
          • 2012
          • 2011
          • 2010
    • Allies
      • NC MAT Naloxone Access Partnerships
    • Work at NCHRC
      • Fair Employment
    • Gallery
  • Programs & Services
    • Syringe Services Programs
    • Overdose Prevention
      • Overdose Prevention Laws in NC
      • Speed Overdose (Overamping)
      • Overdose Prevention Fact Sheets
    • Post Overdose Response and Law Enforcement
      • Georgia Overdose Prevention
      • Georgia OD Prevention and Naloxone Brochure
    • LEAD
      • Law Enforcement Tools and Resources
        • Law Enforcement Voices and Testimony
        • Preventing Occupational Fentanyl and Fentanyl Analog Exposure to Emergency Responders
        • Law Enforcement FAQ on Naloxone and Syringe Exchange
      • LEAD Policies and MOUs
      • US Law Enforcement Who Carry Naloxone
      • Law Enforcement Training Booking and Events
  • Resources
    • Safer Injection Drug Use
    • Safer Sex Work
    • Safer Crack Use
    • Harm Reduction & Trans Health
    • Research
    • Videos
    • Testimonials
  • Advocacy
    • Take Action and Get Involved
      • Inadequate Treatment
    • Legislative Victories
    • Press Releases
    • News and Events
      • News
      • Events
  • Shop NCHRC
  • In Memory of
  • Donate
  • Show Search
Hide Search

Preventing Occupational Fentanyl and Fentanyl Analog Exposure to Emergency Responders

ACMT and AACT Position Statement: The position of the American College of Medical Toxicology (ACMT) and American Academy of Clinical Toxicology (AACT), is as follows: Fentanyl and its analogs are potent opioid receptor agonists, but the risk of clinically significant exposure to emergency responders is extremely low. To date, we have not seen reports of emergency responders developing signs or symptoms consistent with opioid toxicity from incidental contact with opioids. Incidental dermal absorption is unlikely to cause opioid toxicity. For routine handling of drugs, nitrile gloves provide sufficient dermal protection. In exceptional circumstances where there are drug particles or droplets suspended in the air, an N95 respirator provides sufficient protection. Workers who may encounter fentanyl or fentanyl analogs should be trained to recognize the signs and symptoms of opioid intoxication, have naloxone readily available, and be trained to administer naloxone and provide active medical assistance. In the unlikely event of poisoning, naloxone should be administered to those with objective signs of hypoventilation or a depressed level of consciousness, and not for vague concerns such as dizziness or anxiety. In the absence of prolonged hypoxia, no persistent effects are expected following fentanyl or fentanyl analog exposures. Those with small subclinical exposures and those who awaken normally following naloxone administration will not experience long-term effects. While individual practitioners may differ, these are the positions of the American College of Medical Toxicology and the American Academy of Clinical Toxicology at the time written, after a review of the issue and scientific literature.

Copied and Pasted from: https://www.scribd.com/document/354790292/ACMT-and-AACT-Position-Statement

Discover more

Get Help Resources Programs

Footer

NC Harm Reduction Coalition

4024 Barrett Dr.
Suite 101
Raleigh, NC 27609
Email: Executive.Director@nchrc.org

Copyright © 2023 · All Rights Reserved · Website by Tomatillo Design

Connect with Us

  • Facebook
  • LinkedIn
  • Twitter
  • Vimeo